Hodges Capital Management Inc. Acquires 2,573 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hodges Capital Management Inc. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,536 shares of the medical equipment provider’s stock after acquiring an additional 2,573 shares during the period. Hodges Capital Management Inc.’s holdings in Intuitive Surgical were worth $4,205,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the business. Baystate Wealth Management LLC grew its position in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the last quarter. MCF Advisors LLC grew its position in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares during the last quarter. Able Wealth Management LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Atticus Wealth Management LLC grew its position in shares of Intuitive Surgical by 85.4% in the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 41 shares during the last quarter. Finally, MeadowBrook Investment Advisors LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several research reports. Citigroup upped their target price on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. BTIG Research upped their target price on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Stifel Nicolaus increased their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. The Goldman Sachs Group initiated coverage on Intuitive Surgical in a research report on Thursday, May 30th. They set a “buy” rating and a $500.00 price target on the stock. Finally, Jefferies Financial Group increased their price target on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $403.67.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $444.85 on Friday. The business has a fifty day moving average price of $403.83 and a two-hundred day moving average price of $383.12. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $447.11. The stock has a market capitalization of $157.79 billion, a PE ratio of 80.30, a PEG ratio of 5.75 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same period in the prior year, the company earned $1.00 EPS. Intuitive Surgical’s revenue was up 11.5% compared to the same quarter last year. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Insider Activity

In other news, EVP Myriam Curet sold 5,318 shares of the stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total value of $1,971,169.88. Following the completion of the transaction, the executive vice president now directly owns 298 shares in the company, valued at approximately $110,456.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the transaction, the executive vice president now directly owns 298 shares of the company’s stock, valued at approximately $110,456.68. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,956 shares of company stock worth $6,927,011. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.